Specialty Pharmacy

Findings further strengthen the need to protect young people from head injury.

Physical activity and a whole grain-rich diet lowers colorectal cancer risk, whereas red meat increases the risk.

How to avoid common errors in pharmacies to protect patients.

Exposure to carbon may not increase the risk of death among hardmetal workers.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, explains how mobile health can affect specialty pharmacies.

Patients with peripheral neuropathy may experience pain, numbness, and tingling in the hands and feet, despite cessation of chemotherapy.

Findings may lead to future treatments for patients with psoriasis and psoriatic arthritis.

Variation in HPV15 E7 protein greatly decreases the risk of invasive cervical cancer.

A newly-discovered molecule can induce programmed cell death in mesenchymal-like lung cancer cells.

An antibody-immunotherapy combination shows promise against high-risk pediatric cancer.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how technology has influenced the way specialty pharmacists manage patient care.

Top news of the day from across the health care landscape.

Study findings could lead to new treatment options for patients with IBD in the future.

Findings may provide new treatment options for Duchenne muscular dystrophy.

Adjuvant endocrine therapy can prevent cancer recurrence but can result in painful side effects.

Biosimilars offer the potential to provide patients with less costly alternatives.

To control specialty drug costs, many employers have site of care management approaches, while other enact more stringent utilization management procedures.

In 2015, specialty drug costs increased nearly 10%, the highest rate since 2006.

Top news of the week from Specialty Pharmacy Times.

Wnt signaling activation impacts the response to melanoma treatment.

Patients with stage 3 kidney disease cured of hepatitis C virus experienced an improvement in kidney function following treatment.

Company harnesses CRISPR-based gene editing technology as it enters human clinical trials to treat HIV.

Top news of the day from across the health care landscape.

New drug approval highlights the need for value-based payment models for Medicare and Medicaid.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Mvasi is indicated to treat adult patients with certain types of colorectal, lung, brain, kidney, and cervical cancers.

Bevacizumab-awwb, a biosimilar to Avastin, approved to treat several cancer types.